Pipeline ClinicalTrials.gov ↗
What changed
Newest first: trials, label revisions, recalls and reporting spikes.
Upcoming readouts
Open trials with a primary completion date in the next 6 months.
Overdue trials
Still open, past an estimated primary completion date.
Stopped trials
Terminated, withdrawn or suspended, last 3 years, with the reason given.
New trials
Registered in the last 90 days.
Safety reports Label gap →
Emerging reactions
Reactions whose share of the drug's FAERS cases grew most: last 12 months vs the 12 before.
Labels
Current DailyMed label for each brand: revision history and the label's own "Recent Major Changes".
Class-mates Class compare →
Recalls
In the pipeline
Drugs and biologics in the company's open trials, including code names. Click one for its drug dossier.
Competitors in its top conditions
Other lead sponsors with open phase 3 trials in the conditions where this company runs the most open trials.